You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KYMR Sale Disclosure
Booth Bruce · SEC Form 4 · Filed Jun 30, 2026
Sale
Calculated transaction value
$135.98K
Booth Bruce Director
KYMR
Kymera Therapeutics
KYMR
Transaction date
Jun 29, 2026
Public filing date
Jun 30, 2026
Filing lag
Filed 1 day later
KYMR daily price context
Close on/before transaction
$109.32
Jun 29, 2026
First close after public filing
$114.2
Jul 1, 2026
30-day return after filing
-6.3%
Through Jul 30, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,239 shares @ $109.75
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001451612-26-000020
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$3.42M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kymera Therapeutics, Inc. KYMR | Sale | Jun 29, 2026 | $1.15M |
| Kymera Therapeutics, Inc. KYMR | Sale | Jun 29, 2026 | $859.67K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jun 29, 2026 | $841.31K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jun 29, 2026 | $100.86K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jun 29, 2026 | $182.78K |
| Kymera Therapeutics, Inc. KYMR Current | Sale | Jun 29, 2026 | $135.98K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jun 29, 2026 | $132.69K |
| Kymera Therapeutics, Inc. KYMR | Sale | Jun 29, 2026 | $17.46K |